Updated
Reviewed
Aug. 01, 2019
Appendix B: Panel Roster and Financial Disclosures
PML/JCV
| Member | Financial Disclosure | ||
|---|---|---|---|
| Company | Relationship | ||
| Agnihotri, Shruti | University of Alabama at Birmingham | None | N/A |
| Cinque, Paola | San Raffaele Scientific Institute, Milan, Italy | Gilead | Research Support |
| Janssen | Consultant | ||
| Pfizer | Data Safety Monitoring Board | ||
| Shire | Data Safety Monitoring Board | ||
| Clifford, David* | Washington University School of Medicine | Atara | Consultant |
| Biogen Idec | Consultant | ||
| Bristol-Myers Squibb | Consultant | ||
| Dr. Reddy’s Laboratories Inc. | Consultant | ||
| EMD Serono | Consultant | ||
| Genentech | Data Safety Monitoring Board | ||
| Genzyme | Data Safety Monitoring Board | ||
| GlaxoSmithKline | Consultant | ||
| Hoffmann LaRoche | Data Safety Monitoring Board | ||
| Inhibikase Therapeutics | Consultant | ||
| Merck | Data Safety Monitoring Board | ||
| Mitsubishi Tanabe Pharmaceuticals | Consultant | ||
| Pfizer | Consultant | ||
| Quintiles | Data Safety Monitoring Board | ||
| Shire | Data Safety Monitoring Board | ||
| Takeda | Data Safety Monitoring Board | ||
| Wave Life Sciences | Data Safety Monitoring Board | ||
| Marra, Christina | University of Washington School of Medicine | International NeuroHIV Cure Consortium | Consultant |
| Johnson & Johnson | Equity Interest | ||
| McKesson | Equity Interest | ||
| NIH | Research Support | ||
| UpToDate | Royalties | ||
| Wolters Kluwer | Royalties | ||
| Miro, Jose M. | Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain | None | N/A |
| Nath, Avindra | National Institutes of Health | None | N/A |
| * Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019. |
|||
Download Guidelines
- Section OnlyPDF (337.79 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)